|
V.VM
|
The market for contrast media is experiencing rapid growth at a rate of 7.4...
|
|
V.VM
|
Unless manufacturers, providers, and the whole industry work together, the...
|
|
V.VM
|
Based on the MD&A, they have created a new tech to extract iodine from...
|
|
V.VM
|
They are keeping their iodine play tight holed. From MD&A, It is in the...
|
|
V.VM
|
Looks like human testing has begun. See interview https://stockhouse.com/news...
|
|
V.VM
|
Anyone can buy into the p.p. It is not just for existing shareholders.
|
|
V.VM
|
why would people buy in the market when they can get shares 20% cheaper with...
|
|
V.VM
|
https://www.youtube.com/watch?v=Duo2U5Wi5w0 There are many papers in google...
|
|
V.VM
|
Cimbar, Bracco supplier of pharmaceutical grade, no longer has product on its...
|
|
V.VM
|
looks like the new VP bought 100,000 shares. re insider reports. And if you...
|
|
V.VM
|
https://stockhouse.com/news/newswire/2024/10/03/one-best-venture-pharma...
|
|
V.VM
|
Individuals of esteemed background such as Dr. Hashmi and Dr. Sarnachova...
|
|
V.VM
|
You need to go to Proactive Investor website, and watch the latest interview...
|
|
V.VM
|
https://www.paidpromotionalmessages.com/companies/news/1056486/voyageur...
|
|
V.VM
|
Something has to break loose soon. You don't bring on a high profile CSO...
|
|
V.VM
|
https://www.linkedin.com/feed/update/urn:li:activity:7242229253763710976/
|
|
V.VM
|
13.8%, Thats an interesting success rate.
|
|
V.VM
|
The criticism from those lacking education is often surprisingly quick. The...
|
|
V.VM
|
Based on info provided, all we know is they have changed their formulas from...
|
|
V.VM
|
I believe we are closing in on a tipping point for this company. The other...
|